NO311327B1 - Sett for oral prevensjon og regulering av menstruasjon, farmasöytisk preparat og anvendelse - Google Patents

Sett for oral prevensjon og regulering av menstruasjon, farmasöytisk preparat og anvendelse Download PDF

Info

Publication number
NO311327B1
NO311327B1 NO19943234A NO943234A NO311327B1 NO 311327 B1 NO311327 B1 NO 311327B1 NO 19943234 A NO19943234 A NO 19943234A NO 943234 A NO943234 A NO 943234A NO 311327 B1 NO311327 B1 NO 311327B1
Authority
NO
Norway
Prior art keywords
progestin
estrogen
antiprogestin
menstruation
oral
Prior art date
Application number
NO19943234A
Other languages
English (en)
Norwegian (no)
Other versions
NO943234D0 (no
NO943234L (no
Inventor
Gary D Hodgen
Krzysztof Chwalisz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO943234D0 publication Critical patent/NO943234D0/no
Publication of NO943234L publication Critical patent/NO943234L/no
Publication of NO311327B1 publication Critical patent/NO311327B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19943234A 1992-03-02 1994-09-01 Sett for oral prevensjon og regulering av menstruasjon, farmasöytisk preparat og anvendelse NO311327B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84305892A 1992-03-02 1992-03-02
CN93102182A CN1090481C (zh) 1992-03-02 1993-03-02 雌激素/孕激素/抗孕激素的应用,其组合物和药盒
PCT/US1993/001931 WO1993017686A1 (en) 1992-03-02 1993-03-02 Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses

Publications (3)

Publication Number Publication Date
NO943234D0 NO943234D0 (no) 1994-09-01
NO943234L NO943234L (no) 1994-11-01
NO311327B1 true NO311327B1 (no) 2001-11-19

Family

ID=25743002

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19943234A NO311327B1 (no) 1992-03-02 1994-09-01 Sett for oral prevensjon og regulering av menstruasjon, farmasöytisk preparat og anvendelse

Country Status (16)

Country Link
US (1) US7538099B1 (de)
EP (1) EP0630246B1 (de)
JP (1) JP4152431B2 (de)
CN (1) CN1090481C (de)
AU (1) AU678150B2 (de)
BR (1) BR9306005A (de)
CZ (1) CZ291988B6 (de)
FI (1) FI110307B (de)
IL (1) IL104915A (de)
MX (1) MX9301121A (de)
NO (1) NO311327B1 (de)
NZ (1) NZ268304A (de)
PL (2) PL174785B1 (de)
SK (1) SK285963B6 (de)
WO (1) WO1993017686A1 (de)
ZA (1) ZA931492B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
DE4335876A1 (de) * 1993-10-17 1995-04-20 Schering Ag Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
DE19531936A1 (de) * 1995-08-17 1997-02-20 Schering Ag Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
JP2001523639A (ja) 1997-11-14 2001-11-27 アクゾ・ノベル・エヌ・ベー プロゲストゲン−抗プロゲストゲンレジメン
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
WO2000066129A2 (en) * 1999-04-29 2000-11-09 Akzo Nobel N.V. Use of antiprogestagens in combined therapy
RU2145848C1 (ru) * 1999-07-19 2000-02-27 Авакян Гагик Норайрович Средство для лечения вторичной аменореи центрального генеза
UA75339C2 (en) 1999-08-31 2006-04-17 Schering Ag Use of mesoprogestins (progesterone receptor modulators) as pharmaceutical components for manufacture of medicament for hormone replacement therapy (hrt)
MXPA04005445A (es) * 2001-12-05 2005-03-23 Barr Lab Inc Anticonceptivos orales para prevenir el embarazo y disminuir la sintomatologia premenstrual.
JP2006525358A (ja) 2003-05-02 2006-11-09 ドゥラメド ファーマシューティカルズ， インコーポレイテッド 長期周期避妊養生法を利用するホルモン治療の方法
NZ585546A (en) * 2003-07-16 2011-10-28 Teva Womens Health Inc Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
TW200727920A (en) * 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP2868323A1 (de) 2013-11-03 2015-05-06 Flamina Holding AG Pharmazeutische Zusammensetzung oder Gruppe aus Zusammensetzungen zur Hemmung der Herstellung autokriner HCG in adulten humanen Zellen
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
EP3174542A4 (de) 2014-07-29 2018-01-03 TherapeuticsMD, Inc. Transdermale creme
HK1246653A1 (zh) 2014-11-17 2018-09-14 Context Biopharma Inc. 奥那司酮延长释放组合物和方法
CA2986039A1 (en) * 2015-05-18 2016-11-24 Agile Therapeutics, Inc. Contraceptive compositions and methods for improved efficacy and modulation of side effects
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10308676B2 (en) 2015-09-25 2019-06-04 Context Biopharma Inc. Methods of making onapristone intermediates
EP3389632A4 (de) 2015-12-15 2019-11-06 Context Biopharma Inc. Amorphe onapristonzusammensetzungen und verfahren zur herstellung davon
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection
JP2023084729A (ja) * 2021-12-08 2023-06-20 株式会社Ihc 月経誘発キット

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890356A (en) 1973-03-26 1975-06-17 Richardson Merrell Inc 7-Alkyl-{66 {hu 3,5{b -steroids
US3928398A (en) 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
US4416822A (en) 1982-07-09 1983-11-22 The Upjohn Company 17β-Difluoromethyl steroids
IL68222A (en) 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
ES533260A0 (es) * 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos
US4780461A (en) 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
AU572589B2 (en) 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
DE3702383A1 (de) 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US5116818A (en) 1987-03-10 1992-05-26 Medical College Of Hampton Roads Method and kit for contraception with GnRH-antagonist
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
AU1918092A (en) 1992-05-06 1993-11-29 Medical College Of Hampton Roads, The Minimizing progestin associated breakthrough bleeding
US5622943A (en) 1992-05-06 1997-04-22 The Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
US5516769A (en) 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
US5468736A (en) 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
DE4344463A1 (de) 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption

Also Published As

Publication number Publication date
JPH07509218A (ja) 1995-10-12
NZ268304A (en) 1997-02-24
ZA931492B (en) 1993-12-23
NO943234D0 (no) 1994-09-01
WO1993017686A1 (en) 1993-09-16
EP0630246B1 (de) 2008-07-16
SK104694A3 (en) 1996-01-10
FI944022A0 (fi) 1994-09-01
US7538099B1 (en) 2009-05-26
CZ291988B6 (cs) 2003-07-16
PL174785B1 (pl) 1998-09-30
BR9306005A (pt) 1998-06-23
IL104915A (en) 1998-07-15
EP0630246A1 (de) 1994-12-28
CZ211194A3 (en) 1995-12-13
CN1090481C (zh) 2002-09-11
PL172790B1 (pl) 1997-11-28
EP0630246A4 (de) 2002-07-17
MX9301121A (es) 1993-09-01
IL104915A0 (en) 1993-07-08
FI944022L (fi) 1994-09-01
CN1079386A (zh) 1993-12-15
FI110307B (fi) 2002-12-31
AU3787993A (en) 1993-10-05
NO943234L (no) 1994-11-01
JP4152431B2 (ja) 2008-09-17
SK285963B6 (sk) 2007-12-06
AU678150B2 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
EP0630246B1 (de) Verfahren unter verwendung von östrogen/progestin/antiprogestin und vorrichtung zur oralen kontrazeption und zur regulation der menstruation
US5276022A (en) Hormone preparation and method
DK174071B1 (da) Kontraceptivt præparat i form af en pakning omfattende enhedsdoser
US5583129A (en) Composition for contraception
JP2965160B2 (ja) 避妊を達成する組成物
CA2188907C (en) Combination compound for contraception based on natural estrogen
US7704983B1 (en) Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
US5256421A (en) Hormone preparation and method
HUP0202515A2 (hu) Mezoprogesztogének (progeszteron receptor modulátorok) alkalmazása női fogamzásgátló gyógyszer komponenseként
NO169322B (no) Befruktningshindrende preparat med synergistisk virkning
KR100271750B1 (ko) 경구 피임 및 월경 조절을 위한 에스트로겐/프로게스틴/안티프로게스틴 방법 및 키트
CA2134961C (en) Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses
CA1332227C (en) Oral contraceptive formulation
DK174181B1 (da) Farmaceutisk præparat til hormonbehandling
Levine Nondaily hormonal contraceptives: Establishing a fit between product characteristics and patient preferences